© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Human holo-transferrin has roots that tie back to the earliest efforts to unravel how the body moves and stores iron. Decades ago, folks looked at disorders like anemia or iron overload and wondered about the middleman in the blood. What kept vital iron in a safe form, always ready but never toxic? Researchers set to work and discovered transferrin, then figured out how to separate the “holo” (iron-saturated) from the “apo” (iron-free) forms. The clinical push to understand and treat iron-deficiency conditions, especially in newborns and people undergoing heavy blood loss, helped drive more refined purification and characterization techniques throughout the 20th century. Interest really ramped up in the 1970s and 1980s, blending hematology, protein chemistry, and emerging biotech.
Human holo-transferrin stands as an iron-carrier protein, just about the most capable there is at binding iron and keeping it dissolved, non-reactive, and available for cell uptake. Unlike animal-sourced alternatives, this protein matches human biology, which matters for cell cultures and clinical applications. Suppliers today produce it from pooled human plasma or, in some newer versions, recombinant sources. That means more consistency and far fewer worries about pathogens.
Every bottle, vial, or ampoule of holo-transferrin tells the same structural story: roughly 80 kilodaltons mass, heat sensitive, and prone to denaturation outside a narrow pH window close to that of blood. The protein feels nearly invisible in solution, faintly opalescent at high concentrations but never colored unless iron-binding shifts. Its isoelectric point sits around pH 5.5 to 6. A single molecule binds two ferric iron atoms, each clamped into place by a nest of amino acids and a carbonate anion as a co-ligand. High purity brings a negligible lipid or carbohydrate load, and a defined sequence of 679 amino acids.
Any product calling itself “human holo-transferrin” documents source, purity, iron saturation (aiming for 100%), and buffer composition. Endotoxin content and testing for infectious agents get special attention. The technical sheet tells users about typical concentrations—commonly provided freeze-dried or as a 10-100 mg/mL stock. Good suppliers offer certificates of analysis covering UV-Visible spectra (identifying the iron-loaded state by distinctive absorbance about 465 nm), SDS-PAGE purity, and testing for batch-to-batch consistency.
Early on, plasma-derived holo-transferrin relied on lengthy chromatographic procedures, with careful steps to keep iron tightly bound. Researchers treated plasma, precipitated the protein, applied ion-exchange and size-exclusion chromatography, then dialyzed against iron-containing buffers. Now, with recombinant DNA advances, production in CHO or HEK293 cells brings quicker turnaround and less variability. Iron loading typically uses ferric nitrate or ferric chloride under controlled redox conditions, ensuring full saturation. Most prep work gets wrapped up under sterile conditions, followed by filtration or freeze-drying.
Holo-transferrin keeps its iron until strong chelators come along; EDTA, desferrioxamine, and even acidic shifts can yank iron free, a common quality control step. Some researchers peg reactive lysine or arginine residues for labeling, often with fluorophores or biotin, opening the door to imaging and isolation applications. Crosslinkers tack on modifications allowing it to hook to matrices or other proteins, for use in diagnostics or affinity chromatography.
Common language varies between labs and catalogues, with names including “transferrin (human, holo form),” “iron-saturated transferrin,” or abbreviated “Tf(Fe)₂.” Academic papers stick with “holo-transferrin”; commercial lots sometimes bear trademarks, but fundamentally describe the same isolated glycoprotein.
Human-sourced biomolecules walk a fine line between utility and safety concern. Trusted suppliers meet strict regulatory demands for plasma sourcing, often relying on organizations like the American Association of Blood Banks to certify donors. Recombinant versions dodge bloodborne risks. Downstream, labs handle human proteins wearing gloves and using biosafety cabinets. Specific precautions target endotoxin avoidance, absolutely essential for cell culture work, especially when media supplements directly support clinical-grade cells. All waste must be treated as category B biohazard.
Researchers in cell culture media design rely on holo-transferrin to shuttle iron into growing cells, from CHO and hybridoma cultures making monoclonal antibodies to stem cells in regenerative medicine. Clinically, transferrin markers guide diagnosis of iron-related disorders and hereditary hemochromatosis, with direct measurement of transferrin saturation hinting at iron overload or iron-deficiency anemia. Some blood substitutes and parenteral nutrition formulations include it, helping patients absorb or use iron safely without the risk of free, reactive iron. In imaging, labeled holo-transferrin finds cancer cells loaded with transferrin receptors, helping locate tumors. Even beyond that, researchers have been building drug delivery systems using transferrin conjugates to navigate barriers like the blood-brain barrier.
Academics and industry have chased new ways to improve purity, reduce cost, and overcome short shelf life. Recombinant production soared in the last decade, especially after outbreaks of bloodborne viruses. Analytical improvements let folks spot the tiniest impurities. Bioengineering efforts create transferrin analogs bearing extra tags or fusion partners, pushing the protein into roles as a targeting vehicle or therapeutic carrier. Startups aim to dial in iron-release kinetics, providing surgeons and trauma doctors with smarter, longer-lasting iron therapies.
Toxicology lines up iron’s two faces: absolute necessity at trace levels, and serious tissue damage in overload. Holo-transferrin, being fully loaded with iron, steers clear of free radicals as long as it stays whole and in circulation. Experiments in rodents and tissue culture consistently show minimal acute toxicity for pure holo-transferrin. Problems only pop up when iron release gets out of hand, overwhelming the body's recycling system or flooding certain tissues (like in repeated, excessive transfusions). That’s why every clinical program screens for traces of hemoglobin, unconjugated iron, or degraded transferrin.
Looking down the road, human holo-transferrin takes on a bigger role in regenerative medicine as more cell therapies move toward clinical use. Interest grows around using engineered forms to ferry drugs past the blood-brain barrier, which would turn transferrin from a passive carrier into an active therapeutic ingredient. Some teams are designing “smart” transferrin with pH-dependence or stimulus-responsive release, offering nice options for controlling dosing. As diseases targeting iron metabolism—like neurodegeneration or some cancers—demand more precise intervention, holo-transferrin could see expanded use as a diagnostic or even a therapeutic molecule.
You probably haven’t heard much about HOLO-TRANSFERRIN HUMAN unless you spend your days in a lab or a clinic. Still, this protein means a lot to scientists who research how cells grow, repair, and handle iron. HOLO-TRANSFERRIN is the fully loaded form of transferrin, which means it carries iron. By moving iron through the bloodstream and delivering it directly to cells, it supports everything from the formation of healthy red blood cells to the function of immune cells. Without it, iron drifts aimlessly or piles up where it shouldn’t, creating all sorts of problems.
Modern cell culture relies on getting things right to the smallest detail. Researchers use HOLO-TRANSFERRIN HUMAN in their experiments to give cells the iron they crave, but precisely. For cells grown outside the body, iron acts like a double-edged sword: too little and the cells slow down, too much and they start to fall apart. With HOLO-TRANSFERRIN, scientists can skip the guesswork. By adding it directly to dishes where stem cells or specialized cells grow, they help those cells stay healthy and behave more like they do in nature. This step matters when scientists work on diseases like anemia or plan treatments using a patient’s own cells.
Lab-grown red blood cells aren’t science fiction anymore. Getting from stem cells to functional blood means tackling every hurdle, including iron delivery. HOLO-TRANSFERRIN HUMAN helps smooth this process, playing a part in making blood for those who can’t safely get transfusions from donors. It also pops up in tests that measure iron metabolism or diagnose conditions like hemochromatosis—a disorder in which the body stores too much iron. Doctors and lab techs use it to develop better ways to spot iron problems early, which can make a world of difference for folks with chronic disease.
Many scientists remember using transferrin from cows or other animals in the past. Supply was easy, but the cells never quite acted the same as they would with human HOLO-TRANSFERRIN. As research shifted toward therapies that might one day reach real people, using human-sourced proteins became the smarter, safer route. They reduce the chances of immune reactions and strange side effects, which helps keep experiments relevant and future treatments safer.
Cost still stands in the way for many labs. Making pure HOLO-TRANSFERRIN HUMAN means relying on complex purification steps, and that hits budgets hard. Still, researchers and production experts keep finding ways to increase yield and lower contamination. Some labs experiment with recombinant techniques, where they coax bacteria or yeast into making the protein instead. These strategies could help put better, more consistent supplies in the hands of those who need it—without worrying about animal viruses sneaking into the mix.
In a world where stem cell treatments, organ repair, and safer transfusions are on the horizon, getting the basics right comes first. HOLO-TRANSFERRIN HUMAN might sound technical, but it’s a key part of building therapies that actually work and can be trusted. By helping researchers keep their cell cultures healthy, it gives breakthroughs in medicine a real shot—one well-supplied dish at a time.
In a busy lab, proteins like HOLO-TRANSFERRIN HUMAN show up in all sorts of protocols—cell culture, diagnostic work, or biomedical research. With so much riding on its stability, people can’t leave storage to chance. Mishandling invites problems like denaturation and loss of biological activity, and that means wasted time and shaky results. Decades in the lab remind me how one small lapse, like popping a vial in the wrong freezer, can take weeks off a project’s timeline.
Storing HOLO-TRANSFERRIN HUMAN isn’t just about tossing a bottle into any cold space. The molecule’s iron-binding sites and overall structure rely on low temperatures to keep their form. Heat can nudge the protein out of shape, while too many freeze-thaw cycles break fragile bonds and destroy its ability to shuttle iron. Vendors ship most transferrins in lyophilized powder or buffered liquid, but once they land in your lab, the responsibility shifts to you. Hydrophilic proteins like this depend on strict control to prevent degradation.
Across most reputable suppliers, lyophilized HOLO-TRANSFERRIN HUMAN in sealed vials copes best in a -20°C or lower freezer. If left reconstituted or in a diluted buffer, move the tubes to -80°C. I’ve seen teams use standard fridges for short stints, but activity drops quickly—even a few days at 4°C can trim useful shelf life down to nothing. In practical terms: Maestros don’t leave it on the bench, and old timers always keep backup stocks deep-frozen to dodge last-minute disasters.
Dissolved samples bring up another problem—contamination. Protein solutions tempt bacteria and mold, so sterile technique counts. Add a little sodium azide or protease inhibitors if your downstream use allows. Check vendor recommendations, since added agents can clash with cell culture plans or downstream assays.
In crowded fridges, losing track of dates or tube contents spells trouble. I keep a dated log and label every tube with reconstitution details and concentration. Digitizing logs cuts out confusion, especially with rotating staff and multiple projects. Nothing’s more frustrating than picking up a mystery tube and wondering if anyone else opened it last month.
Reputable labs track lot numbers and order from suppliers who vouch for purity and identity, backed by independent certificates of analysis. Stocking small aliquots reduces risk; no one wants the entire supply thawing every few days. If you need to dip into a common vial often, split the batch on day one. Run SDS-PAGE or check absorbance to confirm protein status before critical experiments.
I’ve seen both pro and amateur mistakes—thawing too many times, skipping labels, storing lyophilized vials in humidity-prone fridges. The best results come from keeping a clear schedule, watching freezer temperatures, and treating every tube as valuable as the project itself. Training everyone on these basics secures reliable outcomes whether you’re running cell cultures, chromatography, or bioassays. Secure storage is never just about following rules—it’s the foundation that lets the science stand up to real scrutiny and repeatability.
HOLO-TRANSFERRIN HUMAN gets its name from the fact it’s saturated with iron, unlike its apotransferrin cousin. In labs, it's a staple for feeding cell cultures that crave iron, but its real power only shows up when concentration and purity hit the right marks. A lot of cell lines, from neural stem cells to primary hepatocytes, flounder without a trustworthy source of iron. So, the story isn’t just about science—it’s about giving cells a fighting chance to do what researchers are pushing them to do.
Iron doesn’t just float around in a solution and magically become useful. The typical concentration on most product specs falls around 10 mg/mL, translating to about 125 micromolar in iron content for an average batch. That number gets checked against industry standards, so scientists know how much iron enters their systems. Too much, and cells start to die. Too little, and growth slows to a crawl. Anyone managing high-value cell cultures, especially stem or primary cultures, learns quickly that reliability in concentration saves a lot of frustration and wasted time.
Purity sits right at the center of any reagent’s credibility. Contaminants—especially endotoxins and traces of other plasma proteins—can throw off entire experiments. For HOLO-TRANSFERRIN HUMAN, purity regularly meets or exceeds 95%, measured by SDS-PAGE and trying to keep endotoxin below 1 EU/mg. That’s not just a technical badge; it means less noise in data and fewer false results. Serum-free and chemically defined media make this even more critical. No one wants to wonder if some unexpected variable in supplements caused an experiment to flop.
Every researcher who deals with lab-grade proteins can tell you that supplier traceability matters. Certificates of analysis often include exact concentration, confirmed by UV absorbance at 280 nm, and purity percentages determined after multiple runs. As science asks more of its tools, having transparent specs that back up quality keeps teams honest and projects reproducible. The tools behind the experiment matter as much as the hypothesis.
Organizations that value robust processes often check not just the batch paperwork, but run their own in-lab checks. These include quick spectro reads to confirm iron saturation, and even tiny endotoxin spikes can turn a culture test ugly. The old lesson stands: trust, but verify. Younger colleagues in the lab learn fast that prepping a solid supply chain saves a lot more than just money—it protects months of work.
As stem cell therapies and advanced biologics become less futuristic and more mainstream, the bar for consistent, reliable protein supplements rises, too. Pushing for even higher purity, better batch tracking, and tighter control of iron loading improves not just the end result, but trust across the research community. Labs keep asking for new ideas—perhaps digital batch verification or real-time purity analytics—because chasing better numbers is part of respecting both the science and the patients who stand to benefit.
Stepping into any cell culture lab, you see how much depends on iron’s journey through a dish. Take HOLO-TRANSFERRIN HUMAN—a key player because it brings iron, in the right dose, to the cells trying to grow and thrive. Cell culture doesn’t work with just water and salt. Cells are finicky, and sometimes fail if they don’t get what they expect. From my hands-on time with different growth mediums, human holo-transferrin stands out by giving cells access to iron without bringing along animal-derived surprises.
Cells pull nutrients from their environment, and iron tops their list for things they can’t make on their own. Animal-based transferrin, such as that from bovine sources, carries a risk—cross-species contamination, and unknown variables, especially as regulatory expectations tighten around cell therapy and regenerative research. Transferrin from human plasma carries fewer worries about viral or prion contamination compared to its animal cousin.
I’ve sat through more than a few meetings where the cost of consistency gets a spotlight. Using something derived from human sources means researchers avoid a long list of batch-to-batch surprises. Reports support this, showing human transferrin keeps its iron-holding power longer and delivers iron in the right form, which the cell wants for making DNA and other molecules necessary for division and repair.
Whether growing primary cells from patient biopsies, manufacturing induced pluripotent stem cells, or working with challenging cell lines like hybridomas, you notice right away: quality and growth rate both shift depending on the medium recipe. Human holo-transferrin helps cells reach stable and healthy confluence, supports high-density culture without stress, and avoids the animal product scrutiny that weighs down clinical application research.
In many labs, HOLO-TRANSFERRIN HUMAN fills an important gap for serum-free and chemically defined media. These are more than buzzwords: serum brings mystery and risk, but defined media and human proteins keep the science cleaner. The FDA, EMA, and other regulatory bodies make it clear that xeno-free products help smooth out the approval process for cell therapy products. Every researcher chasing clinical translation wants ways around animal-derived products to avoid getting stuck at the regulatory hurdle.
Even the best resource carries some caution. Relying on pooled human plasma means careful screening and robust purification, otherwise bloodborne nasties can still make an appearance. Top suppliers of human transferrin use viral inactivation and advanced filtering, but any mismatch in purification steps could sneak unwanted proteins or pathogens into the batch.
Cost and availability also shape this decision. Human protein is pricier to source and keep in stock, especially at the scale needed for bioreactor runs or large pharmaceutical production. Labs operating on tighter budgets or with little need for absolute animal-free assurance may still reach for cheaper animal transferrin.
Scientific progress happens in small steps. HOLO-TRANSFERRIN HUMAN gives cell culture a safer run toward clinical application, helps labs trim out animal dependencies, and supports more reliable, consistent research. For anyone growing cells with an eye on human therapy, switching away from animal transferrin isn’t just preferable—it’s the step regulators and patients expect. The cost weighs on the budget side, but with new manufacturing techniques and increased demand, market forces may help balance the expense over time.
Many researchers use HOLO-TRANSFERRIN HUMAN to feed cells with iron in culture. I remember the first time our lab switched to human holo-transferrin. The cells looked healthier and started growing faster. It didn’t take long to realize something as basic as protein quality and reconstitution made or broke cell experiments. Reliable science often starts with preparation and, with this protein, early decisions about buffer and mixing affect the results.
Labs order HOLO-TRANSFERRIN HUMAN in a dry, powdery form. Some folks store it at -20°C, but ambient shelves work if moisture stays out. Once a researcher grabs what’s needed, the process is simple but not mindless. Usually, the label says to use sterile water or a gentle buffer like phosphate-buffered saline. Some add it drop by drop to the container while gently swirling. We learned that rough mixing can denature the protein, turning a helpful tool into an unpredictable variable.
The goal sits at about 10 mg/ml concentration, but I’ve seen colleagues dilute it much further or concentrate it, depending on the need. The temperature also plays a role—cold water helps the protein dissolve evenly. Letting it sit a few minutes before a gentle swirl gets everything mixed. If you see clumps, start over or filter the solution through a tiny-pored filter.
Transferrin carries iron to cells, and cells need iron to grow, repair, and thrive. Impurities or misfolded protein won’t just slow research. They can waste weeks or months if cell lines react poorly. Reconstituting properly, using low-endotoxin or high-purity lots, keeps results meaningful. Manufacturers validate purity, but anyone who’s run a bad batch knows this step never deserves shortcuts.
I’ve seen people shake the vial like it’s a sports drink, and the protein quickly falls apart. Others try to rush, using hot water to speed up the process. Heat easily ruins proteins, and iron falls out of structure without proper care. Using contaminated water brings endotoxins that affect sensitive cells, especially stem or immune cells. Keeping everything clean and slow, watching how the powder dissolves, and filtering correctly almost always saves work later.
If anyone is running into issues, swapping to freshly made buffer or using real-time monitoring for iron content makes a huge difference. Some labs invest in small benchtop kits that check for protein folding or iron amounts. It may feel like overkill, but skipping guesswork brings reproducible results. Asking suppliers for validation paperwork and sharing updates across lab teams can also cut down on wasted time and money. Good prep spreads through the group and ends with better science for everyone, every time.
| Names | |
| Preferred IUPAC name | Iron(III)-transferrin |
| Other names |
TRF Beta-1 metal-binding globulin Siderophilin Serotransferrin |
| Pronunciation | /ˌhoʊ.loʊ.trænzˈfɛr.ɪn ˈhjuː.mən/ |
| Identifiers | |
| CAS Number | 80409-18-1 |
| Beilstein Reference | 3569426 |
| ChEBI | CHEBI:61382 |
| ChEMBL | CHEMBL4296431 |
| ChemSpider | 27523915 |
| DrugBank | DB09131 |
| ECHA InfoCard | 100940 |
| EC Number | EC 3.4.21.108 |
| Gmelin Reference | 526992 |
| KEGG | C14249 |
| MeSH | D015242 |
| PubChem CID | 16132422 |
| RTECS number | DB6210000 |
| UNII | QIY6NJ36Q9 |
| UN number | UN1171 |
| CompTox Dashboard (EPA) | U.S. EPA CompTox Dashboard (DSSTox) Identifier for HOLO-TRANSFERRIN HUMAN: **DTXSID8036252** |
| Properties | |
| Chemical formula | C2932H4512N752O1043S18 |
| Molar mass | 76.5 kDa |
| Appearance | White lyophilized powder |
| Odor | Odorless |
| Density | > 50 mg/mL |
| Solubility in water | soluble in water |
| log P | -5.6 |
| Acidity (pKa) | Acidity (pKa): 6.6 |
| Basicity (pKb) | 6.5 |
| Magnetic susceptibility (χ) | -9.8 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | Refractive index (nD): ~1.334 |
| Dipole moment | 102.5 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 234.3 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | B03BA03 |
| Hazards | |
| Main hazards | May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| GHS labelling | GHS07; GHS08; Warning; H315, H319, H335, H351 |
| Pictograms | MFCD00131045 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| NFPA 704 (fire diamond) | 1-0-0 |
| NIOSH | DS9100056 |
| PEL (Permissible) | 10 mg/m3 |
| REL (Recommended) | 30-50 mg/ml |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
APO-TRANSFERRIN HUMAN TRANSFERRIN RECEPTOR (SOLUBLE) TRANSFERRIN CHICKEN TRANSFERRIN RAT |
